Solving Retail Challenges with Computer Vision

Designed for retail leaders and lovers alike, Retail Refined explores the in-store technology of the future, challenges the industry’s preconceived notions, and brings together retail’s biggest names to understand the brand strategies that will define the next decade in retail.

 

Customer experience, inventory control, and interactions are all challenges for retailers. The pandemic only exasperated them; however, technology is closing the gap. Host Melissa Gonzalez spoke with entrepreneur and technology expert Skip Howard, Co-Founder and CEO of Spacee, about what his company is doing to support retailers.

Spacee has several computer vision and AI products for retailers, including contactless touchscreens and automated inventory solutions that use augmented reality. Howard summed up the company’s niche with, “We use computer vision to solve retail and supply chain problems.”

Since COVID, the company has been a great answer to customers not wanting to touch anything. With their Hover framework, customers can experience the product without contact.

What’s unique about their touchless technology is that it’s not dependent on a touchscreen display. It’s also reusable with a content updated. In designing the product, Howard said, “You can have the greatest tech in the world, but if the UX isn’t good, it won’t matter. We have a UX-first approach.”

On the interactive side of the house, the technology can also attribute and track, modeled on standard KPIs similar to Google Analytics. “The technology can track actions taken with digital experiences, count triggers for conversions, and provide granularity on browsing vs. buying. We also have data scientists that identify trends and practice multi-variant testing, which we deliver to clients,” Howard explained.

They are also assisting grocery stores with inventory management with their Deming Robotics products.

“Grocery stores, in general, are more cash positive right now but dealing with problems in fulfilling online orders, so our robotics products have taken off. Knowing what’s on your shelves in real-time is solving these challenges,” Howard noted.

Gonzalez and Howard also discussed the “what’s next’ for in-store experiences, touching on the future of self-checkout, AI, human interaction, and automation.

Listen to Previous Episodes of Retail Refined Right Here!

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More